LAG3 and breast cancer: To assess these effects, we used a multicolor panel of antibodies to measure the level of expression of exhaustion (CTLA4, PD1, TIM3, and LAG3) and senescence (CD57 and KLRG1) markers on T cells from BC patients before and after NAC using multicolor flow cytometry.